×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share
GlobeNewswire
Sio was a clinical-stage company focused on developing gene therapies to radically transform the lives of patients with neurodegenerative...
3 months ago
AAV Vectors in Gene Therapy Market is Predicted to Observe Skyrocketed Growth During the Study Period (2019-2032 ...
PR Newswire
PRNewswire/ -- DelveInsight's AAV Vectors in Gene Therapy Market Insights report includes a comprehensive understanding of current treatment...
3 months ago
Sio Gene Therapies comes to the end of its rocky road
Pharmaphorum
Sio Gene Therapies' litany of clinical disappointments over the last few years has finally led to the demise of the biotech, formerly known...
16 months ago
UPDATE: Sio Gene Therapies warns of 'significant' layoffs after ditching final 2 assets
Fierce Biotech
Fierce Biotech has learned that Sio Gene Therapies called an all-employee meeting late Wednesday to disclose news of layoffs and the...
24 months ago
SIO GENE THERAPIES INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ...
MarketScreener
On March 14, 2023 , the Company received written notice (the "Delisting Notice") from Nasdaq notifying the Company that, as a result of its...
13 months ago
Development Halted on Parkinson's Therapy Candidate AXO-Lenti-PD
Parkinson's News Today
Sio Gene Therapies (Sio), formerly known as Axovant, intends to stop development of AXO-Lenti-PD, an investigational gene therapy for...
27 months ago
Signs of Trouble Emerge as Sio Gene Halts UMass Gangliosidosis Deal
BioSpace
Sio Gene has terminated its licensing deal with the UMass to develop and commercialize two gene therapy product candidates to focus on more...
24 months ago
How Vivek Ramaswamy made his fortune
Fortune
Republican presidential hopeful and GOP debate punching bag Vivek Ramaswamy grew his net worth while trying to shake up the biotech...
8 months ago
Pharmaceutical Technology
Pharmaceutical Technology
US Elections: Vivek Ramaswamy makes brazen debate debut. Candidates at the first Republican primary debate diverged on abortion access laws, but any further...
7 months ago
Gene and Cell Therapies Targeting CNS Disorders Market is Predicted to Exhibit Remarkable Growth by 2032 ...
GlobeNewswire
The gene and cell therapies targeting CNS disorders market is expected to grow at a significantly high rate and is mainly driven by an...
2 months ago